Cogentix Medical (CGNT) Trading Up 0.5%
Cogentix Medical Inc (NASDAQ:CGNT)’s share price was up 0.5% on Tuesday . The stock traded as high as $3.89 and last traded at $3.84. Approximately 758,871 shares traded hands during trading, an increase of 389% from the average daily volume of 155,262 shares. The stock had previously closed at $3.82.
Several equities analysts have weighed in on CGNT shares. Aegis started coverage on Cogentix Medical in a research note on Friday, December 1st. They set a “buy” rating and a $4.75 target price on the stock. Zacks Investment Research cut Cogentix Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, December 20th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $4.06.
The company has a market cap of $233.27, a P/E ratio of -9.34 and a beta of 0.75.
WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/03/15/cogentix-medical-cgnt-trading-up-0-5.html.
About Cogentix Medical
Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).
Receive News & Ratings for Cogentix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical and related companies with MarketBeat.com's FREE daily email newsletter.